Aurinia Pharmaceuticals Inc.
Hedge Funds Holdings
Last updated:
Aurinia Pharmaceuticals Inc.‘s stocks are currently a part of 175 hedge funds’ portfolios, which represents 33.09% of the total amount of its stocks outstanding. This makes up a total of 42.49M shares of Aurinia Pharmaceuticals Inc.. Compared to the previous quarter, the number grew by 9.96% or 3.84M shares more. As for the holding position changes, 37.71% (66) of current hedge fund investors increased the number of shares held, 25.14% (44) of current holders sold a part of the shares held, and 21.71% (38) closed the holdings completely. 32 hedge funds are new holders of Aurinia Pharmaceuticals Inc. stock in Q1 2022, it is 18.29% of total holders.
Hedge funds holding Aurinia Pharmaceuticals (Q2 2017 – Q1 2022)
| Q2 2017 | 64 |
|---|---|
| Q3 2017 | 61 |
| Q4 2017 | 68 |
| Q1 2018 | 63 |
| Q2 2018 | 65 |
| Q3 2018 | 62 |
| Q4 2018 | 58 |
| Q1 2019 | 76 |
| Q2 2019 | 72 |
| Q3 2019 | 71 |
| Q4 2019 | 112 |
| Q1 2020 | 120 |
| Q2 2020 | 124 |
| Q3 2020 | 140 |
| Q4 2020 | 139 |
| Q1 2021 | 162 |
| Q2 2021 | 160 |
| Q3 2021 | 161 |
| Q4 2021 | 184 |
| Q1 2022 | 175 |
Hedge funds changes in Aurinia Pharmaceuticals positions (Q2 2017 – Q1 2022)
| Q2 2017 | 16 | 23 | 16 | 20 | -11 |
|---|---|---|---|---|---|
| Q3 2017 | 8 | 23 | 13 | 10 | 7 |
| Q4 2017 | 20 | 16 | 16 | 13 | 3 |
| Q1 2018 | 10 | 18 | 17 | 15 | 3 |
| Q2 2018 | 11 | 17 | 17 | 8 | 12 |
| Q3 2018 | 7 | 17 | 14 | 11 | 13 |
| Q4 2018 | 6 | 16 | 18 | 10 | 8 |
| Q1 2019 | 23 | 17 | 18 | 5 | 13 |
| Q2 2019 | 7 | 19 | 25 | 11 | 10 |
| Q3 2019 | 7 | 20 | 20 | 8 | 16 |
| Q4 2019 | 50 | 28 | 18 | 8 | 8 |
| Q1 2020 | 32 | 37 | 27 | 21 | 3 |
| Q2 2020 | 27 | 45 | 30 | 24 | -2 |
| Q3 2020 | 33 | 65 | 27 | 17 | -2 |
| Q4 2020 | 22 | 52 | 41 | 23 | 1 |
| Q1 2021 | 44 | 52 | 46 | 21 | -1 |
| Q2 2021 | 30 | 57 | 40 | 32 | 1 |
| Q3 2021 | 39 | 42 | 49 | 34 | -3 |
| Q4 2021 | 50 | 59 | 53 | 26 | -4 |
| Q1 2022 | 32 | 66 | 44 | 38 | -5 |
Hedge funds changes in Aurinia Pharmaceuticals stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 3,037,000 | 5,611,000 |
|---|---|---|
| Q3 2017 | 2,145,000 | 5,563,000 |
| Q4 2017 | 865,000 | 2,989,000 |
| Q1 2018 | 595,000 | 2,792,000 |
| Q2 2018 | 1,003,000 | 2,423,000 |
| Q3 2018 | 2,407,000 | 3,036,000 |
| Q4 2018 | 896,000 | 2,362,000 |
| Q1 2019 | 3,921,000 | 3,459,000 |
| Q2 2019 | 6,352,000 | 3,810,000 |
| Q3 2019 | 8,660,000 | 8,183,000 |
| Q4 2019 | 89,089,000 | 36,478,000 |
| Q1 2020 | 34,336,000 | 27,959,000 |
| Q2 2020 | 33,791,000 | 24,885,000 |
| Q3 2020 | 38,027,000 | 30,835,000 |
| Q4 2020 | 43,151,000 | 44,941,000 |
| Q1 2021 | 23,922,000 | 31,419,000 |
| Q2 2021 | 34,001,000 | 42,463,000 |
| Q3 2021 | 119,778,000 | 112,099,000 |
| Q4 2021 | 199,306,000 | 123,711,000 |
| Q1 2022 | 96,081,000 | 46,327,000 |